Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Off-target genomic loci represent unintended DNA sequences where a CRISPR-Cas9 complex may bind and induce double-strand breaks (Fu et al., 2013, Nature Biotechnology). In the context of Perforin 1 (PRF1) gene editing, these sites are characterized by partial sequence complementarity to the PRF1-specific guide RNA (gRNA) and the presence of a 5'-NGG-3' Protospacer Adjacent Motif (PAM) (Mojica et al., 2009, Microbiology). While the intended target is the PRF1 gene, which encodes a pore-forming protein essential for the cytotoxic activity of T cells and Natural Killer cells (UniProt KB: P14222), Cas9 can tolerate several mismatches between the gRNA and the genomic DNA. This lack of absolute specificity can lead to permanent mutations at non-target sites, potentially causing genomic instability or the disruption of tumor suppressor genes (National Institutes of Health, NIH). Identifying these loci through methods like GUIDE-seq or CIRCLE-seq is a fundamental requirement for the clinical development of gene therapies targeting PRF1-related disorders, such as Familial Hemophagocytic Lymphohistiocytosis (Tsai et al., 2015, Nature Biotechnology).
Unintended DNA double-strand breaks followed by error-prone repair (NHEJ) or homology-directed repair (HDR) at sites with partial gRNA complementarity and a compatible PAM.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Off-target genomic loci (Perforin 1 guide RNA).